RICHARD D. LENTZ, M.S., M.D.; DAVID M. BROWN, M.D.; CARL M. KJELLSTRAND, M.D.
Grant support: in part by U.S. Public Health Service Grants HL06314 and AI10704 and Training Grant AM08087.
▸Requests for reprints should be addressed to Carl M. Kjellstrand, M.D.; Department of Medicine, University of Minnesota Hospitals, Minneapolis, MN 55455.
LENTZ R., BROWN D., KJELLSTRAND C.; Treatment of Severe Hypophosphatemia. Ann Intern Med. 1978;89:941-944. doi: 10.7326/0003-4819-89-6-941
Download citation file:
Published: Ann Intern Med. 1978;89(6):941-944.
Aspects of phosphate biochemistry pertinent to therapy, the distribution of phosphorus in body compartments, therapeutic phosphorus preparations, prevention of hypophosphatemia, therapeutic guidelines, and side-effects of phosphorus therapy are reviewed. Severe hypophosphatemia (< 0.32 mmol/litre or < 1 mg/dl) can occur with normal or depleted body stores. Because a large amount of phosphorus may shift rapidly between the extracellular and intracellular or bone compartments, the size of a possible total body deficit cannot be estimated from the serum phosphorus level. Similar shifts may occur unpredictably during repair of hypophosphatemia. Therefore, correction of hypophosphatemia in any patient must be empiric and the response of serum levels to therapy should be followed closely. We discuss a method likely to correct hypophosphatemia while minimizing side-effects.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Hospital Medicine, Nephrology, Education and Training.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only